An evaluation of the effects of smoking on codeine pharmacokinetics and bioavailability in normal human volunteers

J. H. Hull, J. W A Findlay, J. F. Rogers, R. M. Welch, R. F. Butz, J. A. Bustrack

Research output: Contribution to journalArticle

Abstract

Cigarette smoking has been shown to increase the clearance of several drugs, including pentazocine, theophylline, and phenacetin. This effect presumably is mediated through enzyme induction, resulting from inhaled polycyclic aromatic hydrocarbons. Because the O-demethylation pathway for codeine is similar to that of other drugs known to be influenced by cigarette smoking, a study was conducted to compare the pharmacokinetics and metabolism of codeine in smokers and nonsmokers. Twelve volunteers with no history of cigarette smoking and ten volunteers who smoke cigarettes were studied; an open, two-treatment, simultaneous parallel and crossover study design was used. Each volunteer received a single dose of codeine sulfate 60 mg po and codeine phosphate 60 mg im, in random treatment order, at one-week intervals. Serial blood samples were collected up to 12 hours after dosing, and plasma codeine and morphine concentrations were measured by immunoassay. There was no significant difference between smokers and nonsmokers in either codeine or morphine areas under the plasma concentration-time curves (AUCs), with either route of administration. The relative codeine bioavailability in these groups was 54.8 ± 4.9 percent and 50.2 ± 2.1 percent (mean ± SE), respectively. Smoking was associated with greater variability in plasma concentrations. Interestingly, greater morphine:codeine AUC ratios were observed in both groups after oral than after intramuscular administration. Cigarette smoking should have no clinically important influence on codeine absorption or disposition.

Original languageEnglish (US)
Pages (from-to)849-854
Number of pages6
JournalDrug Intelligence and Clinical Pharmacy
Volume16
Issue number11
StatePublished - 1982
Externally publishedYes

Fingerprint

Codeine
Biological Availability
Healthy Volunteers
Pharmacokinetics
Smoking
Morphine
Volunteers
Cross-Over Studies
Area Under Curve
Phenacetin
Pentazocine
Enzyme Induction
Polycyclic Aromatic Hydrocarbons
Theophylline
Immunoassay
Smoke
Tobacco Products
Pharmaceutical Preparations
Sulfates

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Hull, J. H., Findlay, J. W. A., Rogers, J. F., Welch, R. M., Butz, R. F., & Bustrack, J. A. (1982). An evaluation of the effects of smoking on codeine pharmacokinetics and bioavailability in normal human volunteers. Drug Intelligence and Clinical Pharmacy, 16(11), 849-854.

An evaluation of the effects of smoking on codeine pharmacokinetics and bioavailability in normal human volunteers. / Hull, J. H.; Findlay, J. W A; Rogers, J. F.; Welch, R. M.; Butz, R. F.; Bustrack, J. A.

In: Drug Intelligence and Clinical Pharmacy, Vol. 16, No. 11, 1982, p. 849-854.

Research output: Contribution to journalArticle

Hull, JH, Findlay, JWA, Rogers, JF, Welch, RM, Butz, RF & Bustrack, JA 1982, 'An evaluation of the effects of smoking on codeine pharmacokinetics and bioavailability in normal human volunteers', Drug Intelligence and Clinical Pharmacy, vol. 16, no. 11, pp. 849-854.
Hull, J. H. ; Findlay, J. W A ; Rogers, J. F. ; Welch, R. M. ; Butz, R. F. ; Bustrack, J. A. / An evaluation of the effects of smoking on codeine pharmacokinetics and bioavailability in normal human volunteers. In: Drug Intelligence and Clinical Pharmacy. 1982 ; Vol. 16, No. 11. pp. 849-854.
@article{d02c3a9a50e74aae8b96f4b721159756,
title = "An evaluation of the effects of smoking on codeine pharmacokinetics and bioavailability in normal human volunteers",
abstract = "Cigarette smoking has been shown to increase the clearance of several drugs, including pentazocine, theophylline, and phenacetin. This effect presumably is mediated through enzyme induction, resulting from inhaled polycyclic aromatic hydrocarbons. Because the O-demethylation pathway for codeine is similar to that of other drugs known to be influenced by cigarette smoking, a study was conducted to compare the pharmacokinetics and metabolism of codeine in smokers and nonsmokers. Twelve volunteers with no history of cigarette smoking and ten volunteers who smoke cigarettes were studied; an open, two-treatment, simultaneous parallel and crossover study design was used. Each volunteer received a single dose of codeine sulfate 60 mg po and codeine phosphate 60 mg im, in random treatment order, at one-week intervals. Serial blood samples were collected up to 12 hours after dosing, and plasma codeine and morphine concentrations were measured by immunoassay. There was no significant difference between smokers and nonsmokers in either codeine or morphine areas under the plasma concentration-time curves (AUCs), with either route of administration. The relative codeine bioavailability in these groups was 54.8 ± 4.9 percent and 50.2 ± 2.1 percent (mean ± SE), respectively. Smoking was associated with greater variability in plasma concentrations. Interestingly, greater morphine:codeine AUC ratios were observed in both groups after oral than after intramuscular administration. Cigarette smoking should have no clinically important influence on codeine absorption or disposition.",
author = "Hull, {J. H.} and Findlay, {J. W A} and Rogers, {J. F.} and Welch, {R. M.} and Butz, {R. F.} and Bustrack, {J. A.}",
year = "1982",
language = "English (US)",
volume = "16",
pages = "849--854",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "11",

}

TY - JOUR

T1 - An evaluation of the effects of smoking on codeine pharmacokinetics and bioavailability in normal human volunteers

AU - Hull, J. H.

AU - Findlay, J. W A

AU - Rogers, J. F.

AU - Welch, R. M.

AU - Butz, R. F.

AU - Bustrack, J. A.

PY - 1982

Y1 - 1982

N2 - Cigarette smoking has been shown to increase the clearance of several drugs, including pentazocine, theophylline, and phenacetin. This effect presumably is mediated through enzyme induction, resulting from inhaled polycyclic aromatic hydrocarbons. Because the O-demethylation pathway for codeine is similar to that of other drugs known to be influenced by cigarette smoking, a study was conducted to compare the pharmacokinetics and metabolism of codeine in smokers and nonsmokers. Twelve volunteers with no history of cigarette smoking and ten volunteers who smoke cigarettes were studied; an open, two-treatment, simultaneous parallel and crossover study design was used. Each volunteer received a single dose of codeine sulfate 60 mg po and codeine phosphate 60 mg im, in random treatment order, at one-week intervals. Serial blood samples were collected up to 12 hours after dosing, and plasma codeine and morphine concentrations were measured by immunoassay. There was no significant difference between smokers and nonsmokers in either codeine or morphine areas under the plasma concentration-time curves (AUCs), with either route of administration. The relative codeine bioavailability in these groups was 54.8 ± 4.9 percent and 50.2 ± 2.1 percent (mean ± SE), respectively. Smoking was associated with greater variability in plasma concentrations. Interestingly, greater morphine:codeine AUC ratios were observed in both groups after oral than after intramuscular administration. Cigarette smoking should have no clinically important influence on codeine absorption or disposition.

AB - Cigarette smoking has been shown to increase the clearance of several drugs, including pentazocine, theophylline, and phenacetin. This effect presumably is mediated through enzyme induction, resulting from inhaled polycyclic aromatic hydrocarbons. Because the O-demethylation pathway for codeine is similar to that of other drugs known to be influenced by cigarette smoking, a study was conducted to compare the pharmacokinetics and metabolism of codeine in smokers and nonsmokers. Twelve volunteers with no history of cigarette smoking and ten volunteers who smoke cigarettes were studied; an open, two-treatment, simultaneous parallel and crossover study design was used. Each volunteer received a single dose of codeine sulfate 60 mg po and codeine phosphate 60 mg im, in random treatment order, at one-week intervals. Serial blood samples were collected up to 12 hours after dosing, and plasma codeine and morphine concentrations were measured by immunoassay. There was no significant difference between smokers and nonsmokers in either codeine or morphine areas under the plasma concentration-time curves (AUCs), with either route of administration. The relative codeine bioavailability in these groups was 54.8 ± 4.9 percent and 50.2 ± 2.1 percent (mean ± SE), respectively. Smoking was associated with greater variability in plasma concentrations. Interestingly, greater morphine:codeine AUC ratios were observed in both groups after oral than after intramuscular administration. Cigarette smoking should have no clinically important influence on codeine absorption or disposition.

UR - http://www.scopus.com/inward/record.url?scp=0020413386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020413386&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 849

EP - 854

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 11

ER -